TRCT
MXCT icon

Tower Research Capital (TRC)’s MaxCyte MXCT Stock Holding History

Tower Research Capital (TRC)’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.2K Buy
25,937
+18,628
+255% +$17.4K ﹤0.01% 3543
2025
Q4 		$11.3K Buy
7,309
+715
+11% +$1.14K ﹤0.01% 3613
2025
Q3 		$10.4K Sell
6,594
-5,705
-46% -$9.91K ﹤0.01% 3981
2025
Q2 		$26.8K Buy
12,299
+7,474
+155% +$18.1K ﹤0.01% 3490
2025
Q1 		$13.2K Sell
4,825
-2,739
-36% -$10.8K ﹤0.01% 3397
2024
Q4 		$31.5K Buy
7,564
+4,173
+123% +$15.8K ﹤0.01% 2874
2024
Q3 		$13.2K Sell
3,391
-9,686
-74% -$40.8K ﹤0.01% 3536
2024
Q2 		$51.3K Buy
13,077
+11,335
+651% +$48.8K ﹤0.01% 3081
2024
Q1 		$7.3K Sell
1,742
-38,252
-96% -$180K ﹤0.01% 4228
2023
Q4 		$188K Buy
39,994
+36,990
+1,231% +$144K ﹤0.01% 2158
2023
Q3 		$9.37K Sell
3,004
-4,153
-58% -$16.7K ﹤0.01% 4227
2023
Q2 		$32.9K Buy
7,157
+49
+0.7% +$225 ﹤0.01% 2944
2023
Q1 		$35K Buy
7,108
+4,144
+140% +$20.4K ﹤0.01% 2842
2022
Q4 		$16K Sell
2,964
-17,712
-86% -$109K ﹤0.01% 3360
2022
Q3 		$134K Buy
20,676
+15,573
+305% +$86.9K ﹤0.01% 2289
2022
Q2 		$24K Buy
5,103
+3,689
+261% +$18.2K ﹤0.01% 3610
2022
Q1 		$9K Sell
1,414
-1,884
-57% -$12.9K ﹤0.01% 4470
2021
Q4 		$33K Sell
3,298
-4,918
-60% -$52.8K ﹤0.01% 3134
2021
Q3 		$100K Buy
+8,216
New +$124K ﹤0.01% 2400

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Tower Research Capital (TRC)'s MXCT Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its MaxCyte (MXCT) stake by 255% in Q1 2026, buying an estimated $17.4K and bringing the position to 25,937 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3543.

Tower Research Capital (TRC) first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $188K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Tower Research Capital (TRC) held 25,937 shares of MaxCyte worth $18.2K as of Q1 2026.
  • Tower Research Capital (TRC) bought 18,628 MaxCyte shares in Q1 2026, an estimated $17.4K.
  • MaxCyte made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3543 holding.
  • Tower Research Capital (TRC) first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s MaxCyte position peaked at $188K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.